Haemonetics VP has 259 shares withheld for taxes

Haemonetics Corp executive Maryanne Maunsell Farris, the VP and Chief Accounting Officer, reported an automatic share disposition tied to equity compensation.

Rhea-AI Filing Summary

Haemonetics Corp executive Maryanne Maunsell Farris, the VP and Chief Accounting Officer, reported an automatic share disposition tied to equity compensation. On the RSU vesting date, 259 shares of common stock were withheld at $71.28 per share to cover tax obligations, rather than sold on the open market. After this tax-withholding event, she beneficially owns 6,242 common shares, a figure that includes previously reported unvested restricted stock units.

Insider Trade Summary

Exercise Price or Tax Liability: 259 shares

Exercise Price or Tax Liability 1 txn

Insider Maunsell Farris Maryanne

Role VP, Chief Accounting Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	259	$71.28	$18K

Holdings After Transaction: Common Stock — 6,242 shares (Direct)

Footnotes (2)

1. F1. Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
2. F2. This number includes unvested RSUs previously reported.

Key Figures

Shares withheld for taxes: 259 shares Withholding price per share: $71.28 per share Shares owned after transaction: 6,242 shares +1 more

4 metrics

Shares withheld for taxes 259 shares Tax-withholding disposition on June 5, 2026 for RSU vesting

Withholding price per share $71.28 per share Value used for 259-share tax withholding

Shares owned after transaction 6,242 shares Direct beneficial ownership after tax withholding, includes unvested RSUs

Tax-withholding share count 259 shares Reported as taxWithholdingShares in transaction summary

Key Terms

restricted stock units, tax obligations, tax-withholding disposition, beneficially owns

4 terms

restricted stock units financial

"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs")"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax obligations financial

"Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units"

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition"

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

beneficially owns financial

"This number includes unvested RSUs previously reported."

Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Haemonetics (HAE) report for Maryanne Maunsell Farris?

Haemonetics reported that VP and Chief Accounting Officer Maryanne Maunsell Farris had 259 common shares withheld to cover taxes upon RSU vesting. This was a tax-withholding disposition, not an open-market sale, and reflects standard treatment of share-based compensation.

How many Haemonetics (HAE) shares were involved in the June 2026 tax withholding?

The filing shows 259 common shares were withheld at $71.28 per share to satisfy tax obligations linked to vested RSUs on June 5, 2026. These shares were delivered back to the issuer as payment rather than sold in the market.

Does the Haemonetics (HAE) Form 4 show an open-market sale by the VP CAO?

No, the Form 4 shows a tax-withholding disposition coded “F,” not an open-market sale. Shares were withheld by the company to pay taxes on vested restricted stock units, which is a routine equity compensation mechanism rather than a discretionary trade.

How many Haemonetics (HAE) shares does Maryanne Maunsell Farris hold after this transaction?

Following the tax-withholding of 259 shares, Maryanne Maunsell Farris beneficially owns 6,242 common shares directly. According to the footnotes, this post-transaction figure also includes unvested restricted stock units that were previously reported.

What does transaction code “F” mean in the Haemonetics (HAE) Form 4?

Transaction code “F” indicates shares were withheld to pay the exercise price or tax liability on equity awards. In this case, 259 shares were withheld for tax obligations related to RSU vesting, so the event reflects tax settlement rather than a voluntary market sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/08/2026 - 04:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Maunsell Farris Maryanne

(Last) (First) (Middle)

125 SUMMER STREET

(Street)

BOSTON MASSACHUSETTS 02110

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HAEMONETICS CORP [ HAE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/05/2026		F		259(1)	D	$71.28	6,242(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.

2. This number includes unvested RSUs previously reported.

	/s/ Thomas V. Powers, attorney-in-fact for Ms. Farris	06/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)